Most bacteria are harmless and do not cause infections. Some, however, are pathogenic and are equipped with special accessories that are used to deliver toxins (also termed "effectors") into the cells of the infected person.
Numerous bacteria that cause disease, ranging from food poisoning to life threatening infection, employ a syringe-like nano-organelle (a specialized part of a cell having a specific function) that is used to inject toxic effectors into attacked host cells. This process is termed a type III secretion system (TTSS). Among these pathogens are Salmonella; the cause of typhoid fever, Yersinia; and enteropathogenic (intestinal) E. coli, which is responsible for the death of up to one million infants per year, mostly in developing countries.
The bacterial syringe employed by these bacteria is an excellent potential target for drugs (not yet available) to combat these diseases. In order to develop such drugs, however, a better understanding of the syringe functions is needed, requiring development of better methods for measuring the syringe activity.
The Hebrew University researchers – Ilan Rosenshine, the Etta Rosensohn Professor of Bacteriology at the Hebrew University Faculty of Medicine, and his associates -- Erez Mills, Kobi Baruch, Xavier Charpentier and Simi Kobi -- have designed a new, real-time test that allows monitoring the syringe activity. Using this test, they have discovered new properties of this system, which might be used to develop drugs that will inhibit the syringe activity and thereby prevent disease and infection by these dangerous pathogens
Their achievement was described in a recent article in the journal Cell Host & Microbe.
Source: The Hebrew University of Jerusalem
Related stories:
Scientists invent novel hydrogels for repairing, regenerating human tissue
University of Delaware scientists have invented a novel biomaterial with surprising antibacterial properties that can be injected as a low-viscosity gel into a wound where it rigidifies nearly on contact--opening the door to the possibility of delivering a targeted payload of cells and antibiotics to repair the damaged tissue.
Salmonella: Trickier than we imagined
Salmonella is serving up a surprise not only for tomato lovers around the country but also for scientists who study the rod-shaped bacterium that causes misery for millions of people.
Caspase-12: Researcher finds new defense mechanism against intestinal inflammation
The body’s first line of defence against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine. This surprising conclusion is just one facet of a study by Dr. Maya Saleh, a researcher at the Research institute of the McGill University Health Centre that will be published in the journal
Cell Host & Microbe on March 12.
Microneedles Could Replace Syringe
The common needle phobia and painful injections could soon be a thing of the past, thanks to a revolutionary new drug-delivery technique developed by a team at the Georgia Institute of Technology, US. The long-practiced method of drug administration has up to now involved the use of hypodermic needles but they have many drawbacks, including pain, risk of infection, and the need for trained staff to perform the injection.
Scientists look at 'syringe' assembly in plague bacteria
Bacteria that cause the bubonic plague avoid death in our bodies by injecting our cells with immune evasion proteins. Scientists have discovered a new way bacteria build and hold the syringes, according to research published in the journal
Microbiology.
Scientists simulate dinosaur digestion in the lab
Scientists from the University of Bonn are researching which plants giant dinosaurs could have lived off more than 100 million years ago. They want to find out how the dinosaurs were able to become as large as they did. In actual fact such gigantic animals should not have existed. The results of the research have now been published in the journal
Proceedings of the Royal Society B.
Radioactive 'Understudy' May Aid Medical Imaging, Drug Development
Broadway stars have understudies. Now, an increasingly popular radioactive isotope has its own stand-in. Developed in part by researchers at the National Institute of Standards and Technology, the substance might ultimately improve medical imaging, speed up clinical trials of many drugs and facilitate efforts to develop more individualized medical treatment.
Honey a better option for childhood cough than OTCs
A new study by a Penn State College of Medicine research team found that honey may offer parents an effective and safe alternative than over the counter children's cough medicines.
